T. Rowe Price Investment Management
CC icon

T. Rowe Price Investment Management’s Chemours CC Stock Holding History

T. Rowe Price Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.6M Buy
1,978,087
+26,288
+1% +$602K 0.03% 439
2026
Q1 		$43M Buy
+1,951,799
New +$34M 0.03% 377

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

T. Rowe Price Investment Management's CC Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Chemours (CC) stake by 1.3% in Q2 2026, buying an estimated $602K and bringing the position to 1,978,087 shares worth $40.6M. The position accounts for 0.03% of the portfolio, ranked #439.

T. Rowe Price Investment Management first reported a position in CC in Q1 2026 and has held it in 2 quarters since. The position peaked at $43M in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • T. Rowe Price Investment Management held 1,978,087 shares of Chemours worth $40.6M as of Q2 2026.
  • T. Rowe Price Investment Management bought 26,288 Chemours shares in Q2 2026, an estimated $602K.
  • Chemours made up 0.03% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #439 holding.
  • T. Rowe Price Investment Management first reported a position in Chemours in Q1 2026 and has held it in 2 quarters since.
  • T. Rowe Price Investment Management's Chemours position peaked at $43M in Q1 2026.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.